Inventor · disambiguated record
Michael Wade
Also filed as: WADE MICHAEL · WADE MICHAEL S
22 granted patents·9 pending applications·879 citations·filing 1991–2023
97Inventor score
Top patents by PatentIndex Score
31 records- 0197US9199908B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2014·Granted Dec 1, 2015·46 cites·11 claims
- 0296US11839631B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2020·Granted Dec 12, 2023·3 cites·10 claims
- 0396US11839596B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2021·Granted Dec 12, 2023·3 cites·7 claims
- 0496US11141393B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Oct 12, 2021·9 cites·10 claims
- 0596US10080730B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 25, 2018·23 cites·11 claims
- 0696US10076505B2Inhalation formulations of TreprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Sep 18, 2018·14 cites·7 claims
- 0796US9713599B2Parenteral formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2015·Granted Jul 25, 2017·18 cites·5 claims
- 0896US7879909B2Use of Treprostinil to treat neuropathic diabetic foot ulcersUNITED THERAPEUTICS CORP·Filed 2005·Granted Feb 1, 2011·63 cites·21 claims
- 0995US6756033B2Method for delivering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2002·Granted Jun 29, 2004·124 cites·10 claims
- 1095US6521212B1Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2000·Granted Feb 18, 2003·149 cites·12 claims
- 1194US8563614B2Use of treprostinil to treat neuropathic diabetic foot ulcersWADE MICHAEL·Filed 2010·Granted Oct 22, 2013·48 cites·9 claims
- 1294US7199157B2Use of treprostinil to improve kidney functionsUNITED THERAPEUTICS CORP·Filed 2004·Granted Apr 3, 2007·120 cites·13 claims
- 1393US10071123B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Sep 11, 2018·21 cites·3 claims
- 1493US10016463B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jul 10, 2018·19 cites·16 claims
- 1592US10842823B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Nov 24, 2020·8 cites·20 claims
- 1690US6054486AUse of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular diseaseUNITED THERAPEUTICS CORP·Filed 1998·Granted Apr 25, 2000·121 cites·17 claims
- 1790USD336557SCat scratching postWADE MICHAEL S·Filed 1991·Granted Jun 15, 1993·45 cites·1 claims
- 1889US12310992B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted May 27, 2025·0 cites·12 claims
- 1989US10695308B2Inhalation formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2018·Granted Jun 30, 2020·2 cites·3 claims
- 2088US8765813B2Use of treprostinil to treat and prevent ischemic lesionsWADE MICHAEL·Filed 2004·Granted Jul 1, 2014·42 cites·41 claims
- 2187US12274684B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted Apr 15, 2025·0 cites·14 claims
- 2283US11666602B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Jun 6, 2023·1 cites·20 claims
- 2382US2023112834A1Parenteral formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 2475US2021177787A1Inhalation formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 2574US2009124697A1Inhalation formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 2671US2020230089A1Inhalation formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2761US2008280986A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 2858US2014018431A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 2956US2013096200A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
- 3054US2012129941A1Treprostinil treatment for interstitial lung disease and asthmaWADE MICHAEL·Filed 2012·Application pending·0 cites
- 3137US2012004307A1Oral treatment of digital ischemic lesionsWADE MICHAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Wade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →